Enhancing clot properties through fibrin-specific self-cross-linked PEG side-chain microgels

Area of Science:

• Biomaterials Science
• Hemostasis and Thrombosis
• Nanotechnology

Background:

• Excessive bleeding is a significant cause of mortality in trauma and surgery.
• Developing effective synthetic hemostatic agents is crucial for managing severe hemorrhage.
• Platelet-mimicking biomaterials offer a promising approach to improve clot formation.

Purpose of the Study:

• To design and characterize novel platelet-like particles (PEG-PLPs) with hemostatic activity.
• To evaluate the ability of PEG-PLPs to enhance fibrin network formation and clot mechanical properties.
• To assess the stability of PEG-PLP-reinforced clots against fibrinolysis.

Main Methods:

• Synthesis of PEG-PLPs using microgels with PEG side-chains and fibrin-targeting antibodies.
• In vitro assessment of PEG-PLP interaction with fibrin and its effect on fibrin network formation.
• Measurement of clot permeability and mechanical properties (Young's modulus) using AFM force spectroscopy.
• In vitro degradation studies using plasmin to evaluate clot stability.

Main Results:

• PEG-PLPs enhanced fibrin network formation by adhering to and cross-linking fibrin fibers.
• PEG-PLP incorporation reduced clot permeability by approximately threefold.
• PEG-PLP-reinforced clots exhibited significantly increased stiffness (Young's modulus of 1770 Pa vs. 460 Pa).
• Clots formed with PEG-PLPs showed enhanced resistance to plasmin-induced degradation, lasting up to 24 hours.

Conclusions:

• Designed platelet-like particles (PEG-PLPs) effectively mimic natural platelet function in promoting hemostasis.
• PEG-PLPs significantly reinforce the fibrin clot structure, improving mechanical stability and reducing permeability.
• These findings suggest PEG-PLPs hold considerable potential as advanced hemostatic agents for clinical applications.